Armata Pharmaceuticals, Inc.
Market Cap
$365.60M
P/E Ratio
-2.08
EPS
$-4.80
Dividend Yield
0.00%
52-Week Range
$1.17 — $16.34
Volume
57.38K
Avg Volume
51.12K
Beta
1.40
Get alerted when ARMP hits your target price.
Free — enter your email to get started
P/E (TTM)
-2.08
Forward P/E
—
PEG Ratio
0.01
P/S (TTM)
93.37
P/B (TTM)
-2.07
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
1.59%
ROA (TTM)
-2.26%
ROIC
—
Gross Margin
0.69%
Operating Margin
-6.37%
Net Margin
—
Debt/Equity
-1.32
Current Ratio
1.19
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.06%
EPS Growth (5Y)
+0.11%
Sales Growth (3Y)
+0.07%
Sales Growth (5Y)
+0.93%
EPS Est (This Year)
$-1.09
EPS Est (Next Year)
$-1.26
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.24
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
36.41M
Float
11.03M
Free Float %
30.29%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
AMEX
IPO Date
1994-05-20
Employees
60
CEO
Deborah L. Birx
Index Membership
—
Website
https://www.armatapharma.com
Armata Pharmaceuticals, Inc. (ARMP) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $365.60M, a P/E ratio of -2.08, ARMP is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ARMP against other stocks using dozens of fundamental and technical filters.
Armata Pharmaceuticals, Inc. (ARMP) has a trailing twelve-month (TTM) P/E ratio of -2.08. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Armata Pharmaceuticals, Inc. (ARMP) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Armata Pharmaceuticals, Inc. (ARMP) has a market capitalization of $365.60 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.